How many insider declarations does 拓新药业 have?

拓新药业 has filed 10 insider declarations with AMF.

Who is the top reporting insider at 拓新药业?

The top reporting insider at 拓新药业 is 蔡玉瑛, based on the count of public filings.

What is the net insider buy vs sell volume on 拓新药业?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

拓新药业: management transactions · France · AMF

SZSE:301089FR·AMFMcap 3.5Bn€

AMF ↗

Browse the full management transaction log of 拓新药业, a listed equity based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €3.5bn. The latest transaction was disclosed on 23 February 2023 — Sale. Among the most active insiders: 蔡玉瑛. All data is accessible without an account.

10

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

10 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

27.06 €

Income statement

Revenue378.3 M€

Gross profit99.8 M€26% margin

Net income−69.7 M€-18.4% margin

Balance sheet & cash

Market cap3.54 Bn€

Total debt3.3 M€

Free Cash Flow−70.6 M€

Last declaration on 23 February 2023

All Executives10 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations